CDAK NASDAQ
Codiak BioSciences, Inc.
1W: +33.3%
1M: +58.7%
3M: -96.5%
1Y: -99.4%
$0.06
Last traded 2023-05-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$23M
+686.8% ▲
Gross Profit
$23M
+686.8% ▲
Operating Income
-$70M
+23.5% ▲
Net Income
-$42M
+53.2% ▲
EPS (Diluted)
$-1.91
+62.6% ▲
EBITDA
-$28M
+31.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Revenue | $0 | $388K | $3M | $23M |
| YoY Growth | +0.0% | +0.0% | +651.3% | +686.8% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $388K | $3M | $23M |
| Gross Margin | — | 100.0% | 100.0% | 100.0% |
| R&D Expenses | $37M | $60M | $74M | $65M |
| SG&A Expenses | $10M | $21M | $20M | $28M |
| Operating Expenses | $46M | $81M | $94M | $92M |
| Operating Income | -$46M | -$80M | -$91M | -$70M |
| Operating Margin | — | -20657.7% | -3119.0% | -303.2% |
| Interest Expense | $0 | $300K | $2M | $3M |
| Income Before Tax | -$45M | -$78M | -$92M | -$37M |
| Tax Expense | $0 | $1M | -$3M | $4M |
| Net Income | -$45M | -$79M | -$89M | -$42M |
| Net Margin | — | -20425.8% | -3050.8% | -181.5% |
| EPS (Diluted) | $-3.40 | $-6.03 | $-5.11 | $-1.91 |
| EBITDA | -$43M | -$75M | -$89M | -$28M |
| Shares Outstanding | 13M | 13M | 17M | 22M |